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ABSTRACT 
International Journal of Exercise Science 10(2): 266-273, 2017 The purpose of this 
study is to determine how caffeine affects exercise blood pressure (BP) and active and passive 
recovery BP after vigorous intensity exercise in physically active college-aged females. Fifteen 
physically active, ACSM stratified low-risk females (age (y): 23.53  4.07, weight (kg): 60.34  3.67, 
height (cm): 165.14  7.20, BMI (kg/m2): 22.18  1.55) participated in two Bruce protocol exercise 
tests. Before each test participants consumed 1) a placebo or 2) 3.3 mg·kg-1 of caffeine at least one 
hour before exercise in a counterbalanced double-blinded fashion.  After reaching 85% of their 
age-predicted maximum heart rate, BP was taken and participants began an active (i.e. walking) 
recovery phase for 6 minutes followed by a passive (i.e. sitting) recovery phase. BP was assessed 
every two minutes in each phase. Recovery times were assessed until active and passive BP 
equaled 20 mmHg and 10 mmHg above resting, respectively. Participants completed each test 1-2 
weeks a part. Maximal systolic and diastolic blood pressures were not significantly different 
between the two trials. Active recovery, passive recovery, and total recovery times were all 
significantly longer during the caffeine trial than the placebo trial. Furthermore, the time to reach 
age-predicted maximum heart rate was significantly shorter in the placebo trial than the caffeine 
trial. While caffeine consumption did not significantly affect maximal blood pressure, it did affect 
active and passive recovery time following vigorous intensity exercise in physically active 
females. Exercise endurance also improved after consuming caffeine in this population. 
 
KEY WORDS: Cardiorespiratory fitness, recreational athlete, exercise test, 
ergogenic aid 
 
INTRODUCTION 
 
Caffeine is one of the most commonly consumed drugs throughout the world and has minimal 
health risks (10). Since caffeine can be found in many foods and drinks, its effect on the body 
and cardiovascular system should not be overlooked. Caffeine has been shown to improve 
mood, enhance psychomotor performance, enhance cognitive performance in healthy 
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volunteers (24) and has diverse physiological effects including central nervous system 
stimulation (14). Caffeine intake has consistently been shown to increase systolic blood 
pressure through its effects on systemic vascular resistance (2). Caffeine is also seen as an 
adenosine antagonist where it stimulates the central nervous system (16)  by preventing the 
repressor effects on arousal (23) and neurotransmitter release (18). Caffeine is an antagonist 
competitor for these adenosine receptors, acting on these receptors in many areas, including 
whole body peripheral circulation and at the brain cortex (5). Evidence has shown that caffeine 
has a broad scope of pharmacologic effects and has been positively associated with cardiac 
stimulation, arrhythmias, and coronary heart disease (24).  
 
In 2004 the World Anti-Doping Agency removed caffeine from the banned substances list (31) 
and the National Collegiate Athletic Association set a high urinary level of 15 µg/mL to be 
tested positive for caffeine (17). This loosening of regulations increases the need for deeper 
investigation on the effects of caffeine during exercise and sport performance. As athletes 
commonly use caffeine as an ergogenic aid (10), it is important to know caffeine’s effect on 
blood pressure during and after exercise.  
 
At rest, caffeine has been shown to have a stimulatory effect on systolic blood pressure and 
diastolic blood pressure (8). However, results from resting measurements are not applicable to 
someone who is exercising. Dosing caffeine relative to body weight is common practice in 
exercise science research. To induce improvements in exercise performance, a dose of 3-6 
mg.kg-1 taken prior to the performance seems to be sufficient (9). An article by Sung assessed 
the effects of 3.3 mg.kg-1 of caffeine on blood pressure during exercise in normotensive healthy 
young men. Sung found that during maximal exercise 44% of their participants had a 
significant increase in systolic and/or diastolic blood pressure during the caffeine trial when 
compared to the placebo trial (27). This is more than twice the number showing such a 
response to exercise alone (27). This suggests that caffeine has an effect on blood pressure 
during exercise in men, suggesting an increased sympathetic response. However, there has 
been a lack of research on the effects of caffeine on women during exercise and sport 
performance (13). 
 
The influence of caffeine on blood pressure and blood pressure recovery in women has not 
been well documented. The purpose of this study is to determine how caffeine affects maximal 
blood pressure and blood pressure recovery after maximal exercise in physically active 
college-aged females. It is hypothesized that caffeine will raise the participant’s maximal blood 
pressure and extend the period of time it takes for blood pressure to recover from maximal 
work. 
 
METHODS 
 
Participants 
In this study, data was collected from 15 physically active college age females. All participants 
signed a written informed consent form approved by and Institutional Review Board and had 
Int J Exerc Sci 10(2): 266-273, 2017 
 
 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
268 
descriptive variables (i.e. age, height, weight, medical history, caffeine usage, and a list of 
medications they were currently taking) recorded. The participants had to be classified as low 
risk individuals by the American College of Sports Medicine’s (ACSM) guidelines. To be 
considered low risk by the ACSM, participants had less than two risk factors for 
cardiovascular disease and no signs, symptoms, or diagnoses of pulmonary, cardiac, or 
metabolic diseases (19). Furthermore, individuals that had no risk factors, had a body mass 
index <25 kg/m2, and were younger than 45 years old are considered to have normal fasting 
glucose levels according to ACSM and to be at low risk without the need of a blood draw. 
Finally, all participants completed a survey determining how much physical activity they 
complete according to the ACSM’s criteria. 
 
Protocol 
This study was a counterbalanced double-blind study. Participants took part in two maximal 
exercise tests after consuming either 1) a placebo or 2) a dosage of 3.3 mg.kg-1 of body weight 
of caffeine. The caffeine was in powder form and was dissolved in 10 oz. of unsweetened 
cranberry juice to hide the bitter taste of the caffeine powder. The placebo drink was 10 oz. of 
the unsweetened cranberry juice. This dosage was used in the Sung study and showed 
significant results in healthy normotensive men (27).  
 
In the 72 hours leading up to each test, participants were asked to refrain from consuming 
food and drinks containing caffeine. They were provided a list of common foods and drinks 
containing caffeine. Rongen et al. found that 72 hours was shown to avoid the effects of 
caffeine tolerance (25). In the 1-2 weeks between trials, participant caffeine consumption was 
not controlled, except the 72-hour period before testing. During each trial participants were 
asked to arrive one hour before the test began. Their resting blood pressure (i.e. sitting position 
with feet flat on the floor and back supported) was taken just prior to consuming the 10 oz. 
placebo or caffeine beverage. The exercise test began one hour after participants consumed the 
beverage. The one hour wait time was the same whether the participant drank the placebo or 
the caffeine beverage. After the hour wait participants performed a maximal treadmill exercise 
test using the Bruce protocol to 85% of their age-predicted heart rate max using the Gellish 
equation (19). 
 
Each participant completed the two maximal treadmill exercise tests using the Bruce Protocol. 
During each test the participant’s rating of perceived exertion (RPE) and heart rate were 
recorded during the last 15 seconds of each minute and their blood pressure was assessed 
during the last minute of each stage. Heart rate was monitored continuously to determine 
when the participant was at 85% of their age predicted maximum heart rate. When this was 
reached, the exercising portion of the test was completed. Blood pressure was immediately 
taken post-exercise and every 2 minutes during the active recovery phase at 2.0 mph and 0% 
grade until the following two criteria were met: 1) blood pressure was within 20 mmHg of 
their resting values and 2) 6 minutes had elapsed post-exercise. After the 6-minute period, 
participants began the passive recovery phase by sitting down until their blood pressure was 
within 10 mmHg of their resting blood pressure. The amount of time it took participants to 
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recover from near maximal exercise was recorded in minutes, as well as the amount of time it 
took participants to reach 85% of their age predicted maximum heart rate. Participants came 
back 1-2 weeks later to perform the second test. 
 
Statistical Analysis 
A repeated measures ANOVA was used to assess if maximal and recovery systolic blood 
pressures and RPEs, were significantly altered following caffeine use. The amount of time it 
took to reach 85% maximal heart rate and exercise recovery was also assessed in minutes using 
a repeated measures ANOVA. The statistical software used was SPSS (IBM, Armonk, New 
York). The level of significance was set at p < 0.05. 
 
RESULTS 
 
Measured values of descriptive characteristics of participants are presented in Table 1. In Table 
2, exercise test characteristics of participants are presented. The participant’s maximal systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were not significantly different 
between the caffeine and placebo trials. However, in the caffeine trial 60% of participants had a 
higher SBP and 40% had a higher DBP when compared to the placebo trial. The caffeine trial 
had significantly longer active recovery (F = 12.923, p = 0.003, η2 = 0.48), passive recovery (F = 
6.167, p = 0.026, η2 = 0.306), and total recovery periods (F = 16.205, p = 0.001, η2 = 0.537)  than 
the placebo trial. The time it took participants to reach their age-predicted maximum heart rate 
was significantly longer in the caffeine trial than the placebo trial (F = 7.445, p = 0.017, η2 = 
0.364). RPE was not significantly different between the two trials. 
 
Table 1. Participant Characteristics (n=15). 
 Mean  SD 
Age (y) 23.53  4.07 
Height (cm) 165.14  7.20 
Weight (kg) 60.34  3.67 
BMI (kg/m2) 22.18  1.55 
Activity (hrs/wk) 3.77  1.18 
Activity (days/wk) 3.53  1.06 
Data are presented as mean  SD.  
 
Table 2. Exercise Test Characteristics. (n=15). 
 0mg Caffeine 3.3mg Caffeine 
Maximal Systolic Blood Pressure (mmHg) 156.13  21.41 161.93  14.18 
Maximal Diastolic Blood Pressure (mmHg) 71.87  8.16 71.87  8.53 
Active Recovery (min) 3.87  1.77 5.47  2.07* 
Passive Recovery (min) 1.47  0.83 2.47  1.30* 
Total Recovery (min) 5.33  2.06 7.93  2.71* 
Time to 85% HR (min) 7.20  1.47 7.40  1.12* 
RPE 13.33  1.88 13.13  1.73 
Data are presented as mean  SD. *Caffeine trial and placebo trial significantly different at p value < 0.05. 
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DISCUSSION 
 
Determining the effects of caffeine intake on near maximal blood pressure and blood pressure 
recovery would help provide information for female athletes, researchers, and practitioners to 
better understand how caffeine affects blood pressure. This study examined caffeine’s 
hemodynamic influences during exercise in physically active, college-aged females that were 
ACSM classified as low risk. While caffeine use did not increase systolic (SBP) or diastolic 
blood pressure (DBP) at near maximal exercise, the total recovery time from near maximal 
exercise was, on average, 2.6 minutes longer in the caffeine trial.  
 
This pattern of results is in contrast with an article by Sung (27). Sung used a population of 
normotensive healthy young men for his study. The study reported a significant increase in 
SBP and DBP (p <0.02) during maximal exercise trial with caffeine consumption compared to a 
non-caffeine trial (27). Current results indicate that caffeine ingestion prior to near maximal 
exercise had no significant effect on near maximal SBP and DBP (p <0.05). Consequently, the 
hypothesis that caffeine would increase SBP and DBP at near maximal exercise was not 
supported. However, the study by Sung ran a maximum exercise test to exhaustion. Two 
different studies also found non-significant differences between SBP and DBP after exercise 
following caffeine consumption. Costa et al. used a submaximal exercise test on a population 
of normotensive active men (6). Daniels et al. used a submaximal cycle ergometry exercise 
session on a population of male and female cyclists (7). These results suggest that caffeine 
consumption does not affect submaximal exercise blood pressures. 
 
The effects of caffeine on systolic blood pressure recovery were shown to be significantly 
longer during active, passive, and total recovery time compared to the placebo trial, based on 
the current results. Therefore, the hypothesis that caffeine would increase recovery time was 
supported. Souza et al. found similar results in a resistance training study assessing the effects 
of caffeine on hemodynamics after a resistance training session. They also found that SBP and 
DBP were significantly elevated for nine hours post-exercise (26).  
 
Current results also indicate that participants took longer to reach 85% of their age predicted 
maximum heart rate in the caffeine trial. A systematic review by the University of Connecticut 
found that across 21 research studies, caffeine improved sport-specific endurance performance 
ranging from -0.3% to 17.3% improvements across studies (9). The present study showed a 
2.7% increase in aerobic endurance. Furthermore, the results from Piha also found heart rate 
responses were lower under the influence of caffeine in ten healthy participants (20). The Piha 
study monitored heart rate responses following standing up and after an isometric handgrip 
test (20).  Further research is needed in this area to determine whether caffeine lowers heart 
rate responses at near maximal and maximal exercise.  
 
Current results showed that RPE was not significantly different between the caffeine trial and 
placebo trial. However, several other studies found that there was a significant reduction in 
RPE after caffeine consumption (11, 12, 29). These studies each tested one of the different 
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aspects of health-related fitness (i.e. muscular strength, muscular endurance, cardiovascular 
endurance, flexibility, body composition). However, there are studies that have found that 
caffeine does not significantly reduce RPE (3, 28). One study in particular found that RPE was 
not significantly altered after caffeine ingestion during intense exercise in active women (1).    
  
A source of variation in the effects of caffeine across these studies may be the tolerance level of 
habitual users. It has been found that caffeine can show significant effects on cognition and 
hemodynamics in habitual users after abstinence (15, 21, 22, 30). Our participants abstained 
from caffeine for 72 hours before each exercise trial (25).  
 
Results from this study were limited by the near maximal nature of the exercise test. A 
maximal test to exhaustion may have shown differences in SBP, DBP, and RPE. Additionally, 
research has shown that habitual caffeine users who abstain from caffeine for at least seven 
days will optimize the ergogenic effect (9). Seven days of caffeine abstinence would have been 
optimal, but we still had significant results with the 72-hour washout period that was deemed 
sufficient in previous research (25). More research is needed on caffeine’s effect on active 
women. Further research is also needed to determine the effects of caffeine on maximal blood 
pressure and blood pressure recovery in a sedentary female population and to determine the 
effects of caffeine on heart rate responses at near maximal exercise. 
 
In summary, current results suggest that caffeine significantly increases active and passive 
recovery time following near maximal exercise in active females. The responses of recovery 
time to caffeine may have clinical and practical significance to those who use ca ffeine before 
exercise. The current study also provides evidence that caffeine has an ergogenic effect on 
endurance and near maximal heart rate responses. Overall, this study shows that a caffeine 
dose of 3.3 mgkg-1 has the potential to lengthen the amount of time it takes to reach near 
maximal heart rate and also increases the amount of time it takes for blood pressure to recover 
from near maximal exercise. 
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